scout
|Videos|October 17, 2022

PARP Inhibitors as Frontline Maintenance Therapy in Ovarian Cancer

Bradley J. Monk, MD, FACOG, FACS, generates a discussion on the use of PARP inhibitors in ovarian cancer treatment.

Newsletter

Stay up to date on the most recent and practice-changing oncology data


Latest CME